These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 21352428

  • 1. KCNJ11 activating mutations cause both transient and permanent neonatal diabetes mellitus in Cypriot patients.
    Ioannou YS, Ellard S, Hattersley A, Skordis N.
    Pediatr Diabetes; 2011 Mar; 12(2):133-7. PubMed ID: 21352428
    [Abstract] [Full Text] [Related]

  • 2. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes.
    Massa O, Iafusco D, D'Amato E, Gloyn AL, Hattersley AT, Pasquino B, Tonini G, Dammacco F, Zanette G, Meschi F, Porzio O, Bottazzo G, Crinó A, Lorini R, Cerutti F, Vanelli M, Barbetti F, Early Onset Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetology.
    Hum Mutat; 2005 Jan; 25(1):22-7. PubMed ID: 15580558
    [Abstract] [Full Text] [Related]

  • 3. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.
    Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shield JP, Sumnik Z, van Rhijn A, Wales JK, Clark P, Gorman S, Aisenberg J, Ellard S, Njølstad PR, Ashcroft FM, Hattersley AT.
    N Engl J Med; 2004 Apr 29; 350(18):1838-49. PubMed ID: 15115830
    [Abstract] [Full Text] [Related]

  • 4. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.
    Flechtner I, de Lonlay P, Polak M.
    Diabetes Metab; 2006 Dec 29; 32(6):569-80. PubMed ID: 17296510
    [Abstract] [Full Text] [Related]

  • 5. The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities.
    Rica I, Luzuriaga C, Pérez de Nanclares G, Estalella I, Aragonés A, Barrio R, Bilbao JR, Carlés C, Fernández C, Fernández JM, Fernández-Rebollo E, Gastaldo E, Giralt P, Gomez Vida JM, Gutiérrez A, López Siguero JP, Martínez-Aedo MJ, Muñoz M, Prieto J, Rodrigo J, Vargas F, Castano L.
    Diabet Med; 2007 Jul 29; 24(7):707-13. PubMed ID: 17490422
    [Abstract] [Full Text] [Related]

  • 6. [Low doses of sulphonyluria as a successful replacement for insulin therapy in a patient with neonatal diabetes due to a mutation of KCNJ11 gene encoding Kir6.2].
    Ille J, Putarek NR, Radica A, Hattersley A, Ellard S, Dumić M.
    Lijec Vjesn; 2010 Jul 29; 132(3-4):90-3. PubMed ID: 20540435
    [Abstract] [Full Text] [Related]

  • 7. Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation.
    D'Amato E, Tammaro P, Craig TJ, Tosi A, Giorgetti R, Lorini R, Ashcroft FM.
    Diabet Med; 2008 Jun 29; 25(6):651-6. PubMed ID: 18544102
    [Abstract] [Full Text] [Related]

  • 8. Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.
    Bremer AA, Ranadive S, Lustig RH.
    Pediatr Diabetes; 2008 Jun 29; 9(3 Pt 1):236-9. PubMed ID: 18221420
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Successful transfer from insulin to oral sulfonylurea in a 3-year-old girl with a mutation in the KCNJ11 gene.
    Al-Mahdi M, Al Mutair A, Al Balwi M, Hussain K.
    Ann Saudi Med; 2010 Jun 29; 30(2):162-4. PubMed ID: 20220270
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Diabetes in infants may be treated with sulfonylurea as a replacement for insulin].
    Lauridsen MH, Boesgaard TW, Pedersen OB, Hansen T, Hertz B.
    Ugeskr Laeger; 2009 Jun 01; 171(23):1923-4. PubMed ID: 19500515
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.
    Shimomura K, Hörster F, de Wet H, Flanagan SE, Ellard S, Hattersley AT, Wolf NI, Ashcroft F, Ebinger F.
    Neurology; 2007 Sep 25; 69(13):1342-9. PubMed ID: 17652641
    [Abstract] [Full Text] [Related]

  • 16. [Glycemic index of meals and postprandial glycemia in patients with permanent neonatal diabetes due to Kir6.2 gene mutations].
    Klupa T, Małecki M, Skupień J, Szalecki M, Jałowiec I, Surdej B, Myśliwiec M, Sieradzki J.
    Przegl Lek; 2007 Sep 25; 64(6):398-400. PubMed ID: 18159846
    [Abstract] [Full Text] [Related]

  • 17. Activating mutations in the KCNJ11 gene encoding the ATP-sensitive K+ channel subunit Kir6.2 are rare in clinically defined type 1 diabetes diagnosed before 2 years.
    Edghill EL, Gloyn AL, Gillespie KM, Lambert AP, Raymond NT, Swift PG, Ellard S, Gale EA, Hattersley AT.
    Diabetes; 2004 Nov 25; 53(11):2998-3001. PubMed ID: 15504982
    [Abstract] [Full Text] [Related]

  • 18. Neonatal diabetes mellitus: description of two Puerto Rican children with KCNJ11 activating gene mutation.
    Nieves-Rivera F, González-Pijem L.
    P R Health Sci J; 2011 Jun 25; 30(2):87-9. PubMed ID: 21682153
    [Abstract] [Full Text] [Related]

  • 19. Relapsing diabetes can result from moderately activating mutations in KCNJ11.
    Gloyn AL, Reimann F, Girard C, Edghill EL, Proks P, Pearson ER, Temple IK, Mackay DJ, Shield JP, Freedenberg D, Noyes K, Ellard S, Ashcroft FM, Gribble FM, Hattersley AT.
    Hum Mol Genet; 2005 Apr 01; 14(7):925-34. PubMed ID: 15718250
    [Abstract] [Full Text] [Related]

  • 20. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood.
    Flanagan SE, Patch AM, Mackay DJ, Edghill EL, Gloyn AL, Robinson D, Shield JP, Temple K, Ellard S, Hattersley AT.
    Diabetes; 2007 Jul 01; 56(7):1930-7. PubMed ID: 17446535
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.